Found 15 results
Name | Type of Offering | Accepted Date |
---|---|---|
Propanc Health Group Corp
See All Filings
|
D | 2013-05-08 |
Amount To Be Raised
$1,500,000
Associated Brokers / Dealers
N/A
CIK Number
0001517681
Filed Document
0001517681-13-000001
Exclusions or Exemptions
N/A
Accepted Date
2013-05-08
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
AUSTRALIA
Revenue or Assets
Decline to Disclose
Type of Security
Option To Acquire
|
||
Propanc Biopharma, Inc.
See All Filings
|
D | 2023-08-15 06:10:58 |
Amount To Be Raised
$45,000
Associated Brokers / Dealers
N/A
CIK Number
0001517681
Filed Document
0001493152-23-028800
Exclusions or Exemptions
506c
Accepted Date
2023-08-15 06:10:58
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
AUSTRALIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Propanc Biopharma, Inc.
See All Filings
|
D | 2019-01-02 17:00:25 |
Amount To Be Raised
$126,000
Associated Brokers / Dealers
N/A
CIK Number
0001517681
Filed Document
0001493152-19-000040
Exclusions or Exemptions
506b
Accepted Date
2019-01-02 17:00:25
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
AUSTRALIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Propanc Biopharma, Inc.
See All Filings
|
D | 2018-10-11 12:50:37 |
Amount To Be Raised
$422,000
Associated Brokers / Dealers
N/A
CIK Number
0001517681
Filed Document
0001493152-18-014363
Exclusions or Exemptions
506b
Accepted Date
2018-10-11 12:50:37
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
AUSTRALIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Propanc Biopharma, Inc.
See All Filings
|
D | 2019-01-02 17:00:27 |
Amount To Be Raised
$105,000
Associated Brokers / Dealers
N/A
CIK Number
0001517681
Filed Document
0001493152-19-000041
Exclusions or Exemptions
506b
Accepted Date
2019-01-02 17:00:27
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
AUSTRALIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Propanc Biopharma, Inc.
See All Filings
|
D | 2023-08-31 16:06:53 |
Amount To Be Raised
$55,000
Associated Brokers / Dealers
N/A
CIK Number
0001517681
Filed Document
0001493152-23-031052
Exclusions or Exemptions
506b
Accepted Date
2023-08-31 16:06:53
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
AUSTRALIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Propanc Biopharma, Inc.
See All Filings
|
D | 2023-10-26 16:07:53 |
Amount To Be Raised
$61,000
Associated Brokers / Dealers
N/A
CIK Number
0001517681
Filed Document
0001493152-23-038382
Exclusions or Exemptions
506b
Accepted Date
2023-10-26 16:07:53
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
AUSTRALIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Propanc Biopharma, Inc.
See All Filings
|
D | 2018-09-17 12:39:04 |
Amount To Be Raised
$158,000
Associated Brokers / Dealers
N/A
CIK Number
0001517681
Filed Document
0001493152-18-013343
Exclusions or Exemptions
506b
Accepted Date
2018-09-17 12:39:04
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
AUSTRALIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Propanc Biopharma, Inc.
See All Filings
|
D | 2018-10-01 09:20:18 |
Amount To Be Raised
$6,315,435
Associated Brokers / Dealers
N/A
CIK Number
0001517681
Filed Document
0001493152-18-013932
Exclusions or Exemptions
506b
Accepted Date
2018-10-01 09:20:18
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
AUSTRALIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Propanc Biopharma, Inc.
See All Filings
|
D | 2023-08-30 16:05:20 |
Amount To Be Raised
$120,000
Associated Brokers / Dealers
N/A
CIK Number
0001517681
Filed Document
0001493152-23-030657
Exclusions or Exemptions
506b
Accepted Date
2023-08-30 16:05:20
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
AUSTRALIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Propanc Health Group Corp
See All Filings
|
D | 2012-05-24 |
Amount To Be Raised
$7,500,000
Associated Brokers / Dealers
N/A
CIK Number
0001517681
Filed Document
0001354488-12-003031
Exclusions or Exemptions
N/A
Accepted Date
2012-05-24
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
AUSTRALIA
Revenue or Assets
No Revenues
Type of Security
Equity
|
||
Propanc Biopharma, Inc.
See All Filings
|
D | 2020-04-17 16:15:26 |
Amount To Be Raised
$450,000
Associated Brokers / Dealers
N/A
CIK Number
0001517681
Filed Document
0001493152-20-006638
Exclusions or Exemptions
506c
Accepted Date
2020-04-17 16:15:26
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
AUSTRALIA
Revenue or Assets
No Revenues
Type of Security
Equity
|
||
Propanc Biopharma, Inc.
See All Filings
|
D | 2023-08-16 16:39:00 |
Amount To Be Raised
$65,000
Associated Brokers / Dealers
N/A
CIK Number
0001517681
Filed Document
0001493152-23-029173
Exclusions or Exemptions
506b
Accepted Date
2023-08-16 16:39:00
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
AUSTRALIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Propanc Biopharma, Inc.
See All Filings
|
D | 2023-08-31 16:08:10 |
Amount To Be Raised
$72,500
Associated Brokers / Dealers
N/A
CIK Number
0001517681
Filed Document
0001493152-23-031053
Exclusions or Exemptions
506b
Accepted Date
2023-08-31 16:08:10
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
AUSTRALIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Propanc Biopharma, Inc.
See All Filings
|
D | 2023-11-03 16:05:33 |
Amount To Be Raised
$40,000
Associated Brokers / Dealers
N/A
CIK Number
0001517681
Filed Document
0001493152-23-039305
Exclusions or Exemptions
506b
Accepted Date
2023-11-03 16:05:33
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
AUSTRALIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|